 |
| CrossRef Text and Data Mining |
| Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining. |
| Triple Combination Therapy Using Metformin, Thiazolidinedione, and a GLP-1 Analog or DPP-IV Inhibitor in Patients with Type 2 Diabetes Mellitus |
| Sun Woo Kim |
|
Diabetes Metab J. 2010;34(6):331-337. Published online December 31, 2010 DOI: https://doi.org/10.4093/kdj.2010.34.6.331 |
|
Triple Combination Therapy Using Metformin, Thiazolidinedione, and a GLP-1 Analog or DPP-IV Inhibitor in Patients with Type 2 Diabetes Mellitus Korean Diabetes Journal. 2010;34(6):331  Second line therapy: type 2 diabetic subjects failing on metformin GLP-1/DPP-IV inhibitorsversussulphonylurea/insulin: For GLP-1/DPP-IV inhibitors Diabetes/Metabolism Research and Reviews. 2012;28:21-25 Patient preference and tolerability of a DPP-4 inhibitor versus a GLP-1 analog in patients with type 2 diabetes mellitus inadequately controlled with metformin: a 24-week, randomized, multicenter, crossover study Therapeutic Advances in Endocrinology and Metabolism. 2015;6(4):141-148 Evaluation of glycemic control by metformin + glitazone + DPP-4 inhibitor + SGLT-2 inhibitor combination in patients with type 2 diabetes quitting basal/bolus insulin therapy Medicine Science | International Medical Journal. 2019;1 To investigate the efficacy of dipeptidyl peptidase-IV (DPP-IV) inhibitor therapy in multiethnic Asian patients with type 2 diabetes mellitus Diabetes Research and Clinical Practice. 2016;120:S123-S124 Efficacy and Safety of Switching From the DPP-4 Inhibitor Sitagliptin to the Human GLP-1 Analog Liraglutide After 52 Weeks in Metformin-Treated Patients With Type 2 Diabetes Diabetes Care. 2012;35(10):1986-1993 GLP-1-based therapy of type 2 diabetes: GLP-1 mimetics and DPP-IV inhibitors Current Diabetes Reports. 2007;7(5):340-347 1275-P: Cost Effectiveness of Using DPP-4i and SGLT2i Combination Therapy vs. Switching to GLP-1 Therapy for the Management of Type 2 Diabetes Diabetes. 2019;68(Supplement_1): Beyond Metformin: Initiating Combination Therapy in Patients with Type 2 Diabetes Mellitus Pharmacotherapy. 2011;31(12S):44S-53S Medium-Term Effect of Add-On Therapy with the DPP-4 Inhibitor, Sitagliptin, in Insulin-Treated Japanese Patients with Type 2 Diabetes Mellitus Diabetes Therapy. 2016;7(2):309-320 |
